VX-702 , >98.0%(HPLC) , 745833-23-2
CAS NO.:745833-23-2
Empirical Formula: C19H12F4N4O2
Molecular Weight: 404.32
MDL number: MFCD11616590
| Pack Size | Price | Stock | Quantity |
| 25mg | RMB280.00 | In Stock |
|
| 100mg | RMB792.00 | In Stock |
|
| others | Enquire |
PRODUCT Properties
| Boiling point: | 555.2±60.0 °C(Predicted) |
| Density | 1.503 |
| storage temp. | -20°C |
| solubility | Soluble in DMSO (up to 40 mg/ml) or in Ethanol (up to 2 mg/ml) |
| form | solid |
| pka | 10.65±0.50(Predicted) |
| color | White |
| Stability: | Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months. |
| InChI | 1S/C19H12F4N4O2/c20-9-4-5-10(14(23)8-9)16-11(18(24)28)6-7-15(26-16)27(19(25)29)17-12(21)2-1-3-13(17)22/h1-8H,(H2,24,28)(H2,25,29) |
| InChIKey | FYSRKRZDBHOFAY-UHFFFAOYSA-N |
| SMILES | Fc1c(c(ccc1)F)N(c2nc(c(cc2)C(=O)N)c3c(cc(cc3)F)F)C(=O)N |
| CAS DataBase Reference | 745833-23-2 |
Description and Uses
VX-
VX-702 is a third generation inhibitor of p38 mitogen-activated protein (MAP) kinases, binding to both p38α and p38β (Kd = 3.7 and 17 nM, respectively) in an ATP-competitive fashion. It inhibits IL-6, IL-1β, and TNF-α production in LPS-primed blood with IC50 values of 59, 122, and 99 ng/ml, respectively. VX-702, at 1 μM, inhibits activation of p38 in platelets by thrombin, U-46619 , or collagen but does not block platelet aggregation in response to collagen. Although orally active, VX-702 provides only transient suppression of biomarkers of inflammation in ongoing rheumatoid arthritis.[Cayman Chemical]
Safety
| Symbol(GHS) | ![]() GHS07 |
| Signal word | Warning |
| Hazard statements | H315-H319 |
| Precautionary statements | P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313 |
| WGK Germany | WGK 3 |
| HS Code | 2933399990 |
| Storage Class | 11 - Combustible Solids |







